-
BeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
31 Mar 2025 10:13 GMT
… and developing innovative treatments that are more … success for its marketed medicines and drug candidates, if approved … regulatory approvals and commercializing pharmaceutical products and its … III study of pemetrexed plus carboplatin compared with …
-
Merck’s Investigational Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Demonstrates Noninferior Pharmacokinetics Compared to Intravenous (IV) KEYTRUDA® (pembrolizumab) in Pivotal 3475A-D77 Trial
27 Mar 2025 15:16 GMT
… S. Food and Drug Administration (FDA) has accepted for … 2025. Additionally, the European Medicines Agency (EMA) has … pemetrexed and platinum chemotherapy, is indicated for the first-line treatment … the impact of pharmaceutical industry regulation and health …
-
TIVDAK® (tisotumab vedotin) Approved by Japan Ministry of Health, Labour and Welfare for the Treatment of Advanced or Recurrent Cervical Cancer that has Progressed on or after Chemotherapy
27 Mar 2025 12:20 GMT
… University School of Medicine. “Cervical cancer treatment has advanced … vinorelbine, gemcitabine, irinotecan or pemetrexed) in 502 patients with … 301 clinical trial and other clinical trials with tisotumab … is an international biotechnology company with a …
-
Junshi Biosciences Announces Approval of sNDA for Toripalimab in Combination with Bevacizumab for 1st-line Treatment of Advanced Hepatocellular Carcinoma
24 Mar 2025 03:53 GMT
… Medical Products Administration (“NMPA”) has approved the supplemental new drug … completed pivotal clinical trials evaluating the safety and … with pemetrexed and platinum as the first-line treatment … of a Chinese pharmaceutical company through its …
-
Vokes Explores Biomarker Testing and Treatment Landscape for EGFR-Mutated Lung Cancer
18 Mar 2025 17:02 GMT
… and Neck Medical Oncology
Division of Cancer Medicine
The University … Do you rechallenge after stopping treatment?
Yes, there can be … do have some trials. We have a trial [NCT06083857] that … al. Osimertinib plus platinum-pemetrexed in newly diagnosed epidermal …
-
Exploring Targeted Treatments and Their AEs in EGFR-Mutated NSCLC
11 Mar 2025 23:28 GMT
… your first-line treatment consideration?
What … in the trial, they give pemetrexed along with … Therapeutics, Gritstone Oncology, Jazz Pharmaceuticals, Takeda, Janssen Research … Mersana, Blueprint Medicines, Alkermes, and Revolution Medicines.
References:
1 …
-
FDA Approved Drug Products Approval List January 2025
11 Mar 2025 11:43 GMT
Approval Date Drug Name Submission Active Ingredients Company … ;16/2025 PEMETREXED DISODIUMNDA #214408 SUPPL-5 PEMETREXED DISODIUM ACCORD HLTHCARE … #761036 SUPPL-51 DARATUMUMAB JANSSEN BIOTECH Approval 01/24…
-
Guidelines for Mesothelioma Now Offer More Treatment Options
08 Mar 2025 00:57 GMT
… and reviewed trials published between 2016 and 2024. A trial that led … .
Kindler is a professor of medicine in the section of hematology … years, we only had 1 treatment, pemetrexed with a platinum agent. Now …
-
ASCO Updates Guidelines for Malignant Pleural Mesothelioma Treatment
05 Mar 2025 19:03 GMT
… phase 3 MARS-2 trial (NCT02040272) performed in … FDA in 2020, is now recommended as a first-line treatment … regimen combining pembrolizumab with pemetrexed and platinum-based chemotherapy. … these individuals, are medicolegal considerations related to asbestos …
-
Human medicines European public assessment report (EPAR): Alimta, pemetrexed, Date of authorisation: 20/09/2004, Revision: 28, Status: Authorised
05 Mar 2025 14:31 GMT
For the treatment of malignant pleural mesothelioma, Alimta in combination with cisplatin has been compared with cisplatin alone in one main study in 456 patients who had not received chemotherapy for their disease before.
For the treatment of locally …
About
© 1995-2025